業績

HOME > 業績 > 2018年

業績

2018年

  1. Iacucci M, Furfaro F, Matsumoto T, Uraoka T, Smith S, Ghosh S, Kiesslich R. Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era. Gut. 2018 Dec 22. pii: gutjnl-2017-315235. doi: 10.1136/gutjnl-2017-315235. [Epub ahead of print]
  2. Iacucci M, McQuaid K, Gui XS, Iwao Y, Lethebe BC, Lowerison M, Matsumoto T, Shivaji UN, Smith SCL, Subramanian V, Uraoka T, Sanduleanu S, Ghosh S, Kiesslich R. A multimodal (FACILE) classification for optical diagnosis of inflammatory bowel disease associated neoplasia. Endoscopy. 2018 Dec 12. doi: 10.1055/a-0757-7759. [Epub ahead of print]
  3. Nishizawa T, Suzuki H, Arita M, Kataoka Y, Fukagawa K, Ohki D, Hata K, Uraoka T, Kanai T, Yahagi N, Toyoshima O. Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy. J Clin Biochem Nutr. 2018 Nov;63(3):230-232.
  4. Takeuchi Y, Sawaya M, Oka S, Tamai N, Kawamura T, Uraoka T, Ikematsu H, Moriyama T, Arao M, Ishikawa H, Ito Y, Matsuda T. Efficacy of autofluorescence imaging for flat neoplasm detection: a multicenter randomized controlled trial (A-FLAT trial). Gastrointest Endosc. 2018 Nov 16. pii: S0016-5107(18)33283-8. doi: 10.1016/j.gie.2018.11.012. [Epub ahead of print]
  5. Takatori Y, Kato M, Sunata Y, Hirai Y, Kubosawa Y, Abe K, Takada Y, Hirata T, Banno S, Wada M, Kinoshita S, Mori H, Takabayashi K, Kikuchi M, Kikuchi M, Suzuki M, Uraoka T. Impaired activity of daily living is a risk factor for high medical cost in patients of non-variceal upper gastrointestinal bleeding. Surg Endosc　doi: 10.1007/s00464-018-6433-4. [Epub ahead of print], 2018
  6. Nemoto D, Suzuki S, Mori H, Katsuki S, Iwaki T, Aizawa M, Takeuchi Y, Uraoka T, Matsuda T, Fujita T, Hewett DG, Togashi K. Inhibitory Effect of Lidocaine on Colonic Spasm during Colonoscopy: A Multicenter Double-Blind, Randomized Controlled Trial. Dig Endosc　doi: 10.1111/den.13272. [Epub ahead of print], 2018
  7. Nishizawa T, Banno S, Kinoshita S, Mori H, Nakazato Y, Hirai Y, Kubosawa Y, Sunata Y, Matsushita M, Uraoka T. Feasibility of endoscopic mucosa-submucosa clip closure method (with video). Endosc Int Open 6(8):E1070-E1074, 2018
  8. Kato M, Abe K, Kubosawa Y, Sunata Y, Hirai Y, Hirata T, Takada Y, Wada M, Takatori Y, Banno S, Kinoshita S, Mori H, Takabayashi K, Kikuchi M, Shiraishi J, Uraoka T. Validation of treatment algorithm based on the Japan narrow-band imaging expert team classification for sub-centimeter colorectal polyps. Endosc Int Open 6(8):E934-E940, 2018
  9. Kubosawa Y, Nishizawa T, Kinoshita S, Nakazato Y, Uraoka T. Cold snare polypectomy for polyp adjacent to colonic diverticulum. VideoGIE 3(3):85-86, 2018
  10. Yahagi N, Kato M, Ochiai Y, Maehata T, Sasaki M, Kiguchi Y, Akimoto T, Nakayama A, Fujimoto A, Goto O, Uraoka T. Outcomes of endoscopic resection for superficial duodenal epithelial neoplasia. Gastrointest Endosc 88(4):676-682, 2018
  11. Kinoshita S, Nishizawa T, Banno S, Uraoka T. Chemotherapy followed by gastric endoscopic submucosal dissection. Jpn J Clin Oncol 48(6):598-599, 2018
  12. Wada M, Kato M, Hirai Y, Kubosawa Y, Sunata Y, Abe K, Hirata T, Takada Y, Banno S, Takatori Y, Kinoshita S, Mori H, Takabayashi K, Kikuchi M, Kikuchi M, Suzuki M, Kanai T, Uraoka T. Initial Management of Colonic Diverticular Bleeding: Observational Study. Digestion 98(1):41-47, 2018
  13. Ichihara S, Uraoka T, Oka S Challenges associated with the pathological diagnosis of colorectal tumors less than 10 mm in size. Dig Endosc. Suppl 1:41-44, 2018
  14. Uraoka T, Oka S, Ichihara S, Iwatate M, Tamai N, Kawamura T, Takeuchi Y, Mori Y, Yoshii S, Hashimoto S, Ho SH, Chiu HM. Endoscopic management of colorectal tumors less than 10 mm in size: Current status and future perspectives in Japan from a questionnaire survey. Dig Endosc. Suppl 1:36-40, 2018
  15. Iwatate M, Sano Y, Tanaka S, Kudo SE, Saito S, Matsuda T, Wada Y, Fujii T, Ikematsu H, Uraoka T, Kobayashi N, Nakamura H, Hotta K, Horimatsu T, Sakamoto N, Fu KI, Tsuruta O, Kawano H, Kashida H, Takeuchi Y, Machida H, Kusaka T, Yoshida N, Hirata I, Terai T. Validation study for development of the Japan NBI Expert Team classification of colorectal lesions. Dig Endosc. 30(5):642-651, 2018
  16. Fujimoto A, Akimoto T, Nakayama A, Mikami S, Tsujikawa H, Kameyama K, Okamoto S, Maehata T, Ochiai Y, Goto O, Kato M, Sasaki M, Uraoka T, Yahagi N. A Gastric Follicular Lymphoma Presenting as a Submucosal Tumor with a Diagnosis Determined by Endoscopic Resection. Intern Med 57(13):1849-1853, 2018
  17. Takatori Y, Kato M, Sunata Y, Hirai Y, Kubosawa Y, Abe K, Takada Y, Hirata T, Banno S, Wada M, Kinoshita S, Mori H, Takabayashi K, Kikuchi M, Kikuchi M, Suzuki M, Uraoka T. The Role of History of Gastro-Duodenal Ulcer in Patients with Upper Gastrointestinal Bleeding. Dig Dis. 36(3):177-181, 2018
  18. Kato M, Kubosawa Y, Hiarai Y, Abe K, Hirata T, Takada Y, Wada M, Takatori Y, Kinoshita S, Takabayashi K, Kikuchi M, Ohishi T, Uraoka T. Usefulness of Mean Corpuscular Volume for Detection of Advanced Colorectal Cancer in Patients Older than 85 Years. Digestion 97(2):177-182, 2018
  19. Mehta N, Strong AT, Franco M, Stevens T, Chahal P, Jang S, Lopez R, Patil D, Abe S, Saito Y, Uraoka T, Vargo J, Bhatt A. Optimal injection solution for endoscopic submucosal dissection: A randomized controlled trial of Western solutions in a porcine model. Dig Endosc. 30(3):347-353, 2018
  20. Kinoshita S, Nishizawa T, Uraoka T. Progression to invasive cancer from sessile serrated adenoma/polyp. Dig Endosc. 30(2):266, 2018
  21. Nishizawa T, Akimoto T, Uraoka T, Mitsunaga Y, Maehata T, Ochiai Y, Fujimoto A, Goto O, Kanai T, Yahagi N. Endoscopic string clip suturing method: a prospective pilot study (with video). Gastrointest Endosc. 87(4):1074-1078, 2018
  22. Kinoshita S, Uraoka T, Nishizawa T, Naganuma M, Iwao Y, Ochiai Y, Fujimoto A, Goto O, Shimoda M, Ogata H, Kanai T, Yahagi N. The role of colorectal endoscopic submucosal dissection in patients with ulcerative colitis. Gastrointest Endosc. 87(4):1079-1084, 2018
  23. Fujimoto A, Uraoka T, Nishizawa T, Shimoda M, Goto O, Ochiai Y, Maehata T, Akimoto T, Mitsunaga Y, Sasaki M, Yamamoto H, Yahagi N.　Rebamipide solution: a novel submucosal injection material to promote healing speed and healing quality of ulcers induced by endoscopic submucosal dissection.　Gastrointest Endosc　87(4):1114-1120, 2018
  24. Banno S, Kato M, Sunata Y, Hirai Y, Kubosawa Y, Abe K, Takada Y, Hirata T, Takatori Y, Wada M, Kinoshita S, Mori H, Takabayashi K, Kikuchi M, Uraoka T. Risk Factor for Vital Signs Fluctuation during Colonoscopy under Conscious Sedation Consisting of Midazolam and Meperidine. Dig Dis. 36(2):113-117, 2018
  25. Tominaga K, Sakata Y, Kusunoki H, Odaka T, Sakurai K, Kawamura O, Nagahara A, Takeuchi T, Fujikawa Y, Oshima T, Kato M, Furuta T, Murakami K, Chiba T, Miwa H, Kinoshita Y, Higuchi K, Kusano M, Iwakiri R, Fujimoto K, Tack JF, Arakawa T. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study) Neurogastroenterology ＆ motility doi: 10.1111/nmo.13319. [Epub ahead of print], 2018
  26. Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M.　Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 1　Esophagus.　Doi: 10.1007/s10388-018-0641-9. [Epub ahead of print] , 2018
  27. Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 Esophagus. doi: 10.1007/s10388-018-0642-8. [Epub ahead of print] , 2018
  28. Kinoshita Y, Kusano M, Iwakiri K, Fujishiro M, Tachikawa N, Haruma K. Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study. Curr Ther Res Clin Exp. 88:26-34. , 2018
  29. Kawachi K, Sakata Y, Hara M, Takeshita E, Kawakubo H, Yamaguchi D, Okamoto N, Shimoda R, Iwakiri R, Tsuruoka N, Kusano M, Fujimoto K. Higher frequency of upper gastrointestinal symptoms in healthy young Japanese females compared to males and older generations. Esophagus. 15(2):83-87, 2018
  30. Akiyama J, Kuribayashi S, Baeg MK, de Bortoli N, Valitova E, Savarino EV, Kusano M, Triadafilopoulos G. Current and future perspectives in the management of gastroesophageal reflux disease. Ann N Y Acad Sci. doi: 10.1111/nyas.13850. [Epub ahead of print], 2018
  31. Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM, Brainard DM, McHutchison JG, Mochida S, Mizokami M. Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals. Hepatol Int. 12(4):356-367. 2018
  32. Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VW. Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative. Aliment Pharmacol Ther. 47(6):816-825. 2018
  33. Sato K, Naganuma A, Nagashima T, Hoshino T, Uehara D, Arai Y, Horiuchi K, Yuasa K, Takayama H, Arai H, Hatanaka T, Ohyama T, Tahara H, Sohara N, Kobayashi T, Horiguchi N, Yamazaki Y, Kakizaki S, Kusano M, Yamada M, Murase T, Nakamura T. Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin. Hepatol Res. 48(3):E347-E353. 2018
  34. Hatanaka T, Arai H, Shibasaki M, Tojima H, Takizawa D, Toyoda M, Takayama H, Abe T, Sato K, Kakizaki S, Yamada M. Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon-occluded transcatheter arterial chemoembolization: A retrospective cohort study. Hepatol Res. 48(2):165-175, 2018
  35. Suzuki K, Endo R, Takikawa Y, Moriyasu F, Aoyagi Y, Moriwaki H, Terai S, Sakaida I, Sakai Y, Nishiguchi S, Ishikawa T, Takagi H, Naganuma A, Genda T, Ichida T, Takaguchi K, Miyazawa K, Okita K. Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase 2/3, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase 3, multicenter, open trial. Hepatology Research 48(6):411-423. doi: 10.1111/hepr.13045. Epub 2018 Jan 19
  36. Akuta N, Toyota J, Karino Y, Ikeda F, Ido A, Tanaka K, Takaguchi K, Naganuma A, Tomita E, Chayama K, Fujiyama S, Inada Y, Yoshiji H, Watanabe H, Ishikawa H, McPhee F, Noviello S, Kumada H. Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection. Gastroenterol. 53(9):1089-1097, 2018
  37. Oka S, Higuchi T, Furukawa H, Nakamura M, Komori A, Abiru S, Nagaoka S, Hashimoto S, Naganuma A, Naeshiro N, Yoshizawa K, Shimada M, Nishimura H, Tomizawa M, Kikuchi M, Makita F, Yamashita H, Ario K, Yatsuhashi H, Tohma S, Kawasaki A, Tsuchiya N, Migita K. Association of a single nucleotide polymorphism in TNIP1 with type-1 autoimmune hepatitis in the Japanese population. J Hum Genet. [Epub ahead of print], 2018
  38. Sasaki Y, Iwasa S, Okazaki S, Goto M, Kojima Y, Naganuma A, Nagashima K, Nagai Y, Hirano H, Honma Y, Takashima A, Kato K, Hamaguchi T. A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer. Gastric Cancer. 21(3):439-445. 2018
  39. Chayama K, Suzuki F, Karino Y, Kawakami Y, Sato K, Atarashi T, Naganuma A, Watanabe T, Eguchi Y, Yoshiji H, Seike M, Takei Y, Kato K, Alves K, Burroughs M, Redman R, Pugatch DL, Pilot-Matias TJ, Krishnan P, Oberoi RK, Xie W, Kumada H. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis. J Gastroenterol. 53(4):557-565, 2018
  40. Uehara D, Tojima H, Kakizaki S, Yamazaki Y, Horiguchi N, Takizawa D, Sato K, Yamada M, Uraoka T. Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis. Dig Liver Dis. 2018 Oct 22. pii: S1590-8658(18)31202-7. doi: 10.1016/j.dld.2018.10.008. [Epub ahead of print]
  41. Suga T, Kikuchi O, Kobayashi M, Matsui S, Yokota-Hashimoto H, Wada E, Kohno D, Sasaki T, Takeuchi K, Kakizaki S, Yamada M, Kitamura T. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels. Mol Metab. [Epub ahead of print], 2018
  42. Uehara D, Seki Y, Kakizaki S, Horiguchi N, Tojima H, Yamazaki Y, Sato K, Yamada M, Uraoka T, Kasama K. Long-term results of bariatric surgery for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis treatment in morbidly obese Japanese patients Obes Surg. 2018 Dec 12. doi: 10.1007/s11695-018-03641-2.
  43. Uehara D, Hayashi Y, Seki Y, T Kakizaki S, Horiguchi N, Tojima H, Yamazaki Y, Sato K, Yasuda K, Yamada M, Uraoka T, Kasama K. Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology World J Hepatol. 2018 Dec 27;10(12):934-943
  44. Shibuya K, Ohno T, Katoh H, Okamoto M, Shiba S, Koyama Y, Kakizaki S, Shirabe K, Nakano T. A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger. Radiother Oncol. [Epub ahead of print], 2018
  45. Naganuma A, Hoshino T, Ohno N, Ogawa Y, Murakami T, Horiguchi S, Uehara D, Suzuki Y, Hatanaka T, Kudo T, Ishihara H, Sato K, Kakizaki S, Takagi H. β-Hydroxy-β-methyl butyrate/L-arginine/L-glutamine supplementation for preventing hand–foot skin reaction in sorafenib for advanced hepatocellular carcinoma. In Vivo [Epub ahead of print], 2018
  46. Shimoyama Y, Hosaka H, Kuribayashi S, Kawamura O and Kusano M.　Herbal Medicine 　Functional Dyspepsia Evidences in Pathophysiology and Treatment　147-152, 2018
  47. Hatanaka T, Arai H, Kakizaki S. Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Hepatol. 10(7):485-495. 2018
  48. Sato K, Uraoka T. The Risk of Hepatocellular Carcinoma is increased・in Hepatitis C Virus Patients Treated with Interferonfree Direct-acting Antiviral-based Therapy: True or False? Biomed J Sci & Tech Res in press , 2018
  49. Sato K, Uraoka T. A challenge to overcome: NS5A-P32 deletion in DAA-based therapy for HCV World J of Gastroenterol 2018 Oct 14;24(38):4304-4310.
  50. Shiina S, Sato K, Tateishi R, Shimizu M, Ohama H, Hatanaka T, Takawa M, Nagamatsu H, Imai Y. Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery. Can J Gastroenterol Hepatol 2018:4756147
  51. Sunata Y, Nishizawa T, Kinoshita S, Takabayashi K, Uraoka T. A lesson from inappropriate single closure of a perforation during endoscopic submucosal dissection Endoscopy 50(1):E25-E26, 2018
  52. Sunata Y, Mori H, Hirai Y, Kubosawa Y, Banno S, Kinoshita S, Nakazato Y, Nishizawa T, Kikuchi M, Uraoka T. A Case of Gastroparesis after Cryoballoon Ablation followed by Medication- Induced Recovery within 5 Months. Case Rep Gastroenterol. 12(2):473-478, 2018
  53. Takakusagi S, Sato K, Suzuki Y, Yamazaki Y, Kosone T, Kakizaki S, Kusano M, Takagi H. Improvement of Proteinuria due to Combination Therapy with Daclatasvir and Asunaprevir in Hepatitis C Virus-associated Renal Disease without Cryoglobulinemia. Intern Med. 57;2189-2195, 2018
  54. Ikeuchi H, Koinuma K, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Yamazaki Y, Okamoto H, Mimura T, Mochida S, Nojima Y, Hiromura K. Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review. Case Rep Rheumatol. 2018 Jul 26;2018:6873276. doi: 10.1155/2018/6873276.
  55. Hatanaka T, Naganuma A, Saito T, Hoshino T, Kakizaki S, Kumasaka T, Takamoto T, Makuuchi M. A Case of Intratumoral Hemorrhage of Liver Metastasis from a Rectal Neuroendocrine Tumor. Intern Med Sep 12. [Epub ahead of print], 2018
  56. Takakusagi S, Sato K, Suzuki Y, Kobayashi T, Kakizaki S, Takagi H. Possible improvement of liver steatosis associated with elevated creatine phosphokinase level due to subclinical hypothyroidism by thyroid hormone replacement therapy. Biomedical Journal of Scientific & Technical Research 4(1) 2018. 4